IDH1 mutations are found in more than 70% of WHO grade II/ III astrocytomas and oligodendrogliomas as well as in secondary GB [6], therefore linking IDH1 mutation predominantly to lower grade and grade III gliomas, as well as GB having evolved from the aforementioned. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).